BCM
Bayesian Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Sell |
9,500
-4,700
| -33% | -$872K | 0.28% | 102 |
|
|
2025
Q1 | $2.98M | Buy |
+14,200
| New | +$2.98M | 0.49% | 48 |
|
|
2023
Q4 | – | Sell |
-3,500
| Closed | -$522K | – | 705 |
|
|
2023
Q3 | $522K | Buy |
+3,500
| New | +$522K | 0.06% | 364 |
|
|
2021
Q4 | – | Sell |
-5,063
| Closed | -$546K | – | 363 |
|
|
2021
Q3 | $546K | Sell |
5,063
-41,237
| -89% | -$4.45M | 0.16% | 175 |
|
|
2021
Q2 | $5.22M | Buy |
+46,300
| New | +$5.22M | 1.36% | 12 |
|
|
2020
Q4 | – | Sell |
-83,700
| Closed | -$7.33M | – | 434 |
|
|
2020
Q3 | $7.33M | Buy |
83,700
+72,023
| +617% | +$6.31M | 1.79% | 5 |
|
|
2020
Q2 | $1.15M | Sell |
11,677
-2,530
| -18% | -$248K | 0.25% | 107 |
|
|
2020
Q1 | $1.08M | Sell |
14,207
-6,893
| -33% | -$525K | 0.23% | 110 |
|
|
2019
Q4 | $1.87M | Buy |
+21,100
| New | +$1.87M | 0.32% | 67 |
|
|
2019
Q3 | – | Sell |
-5,800
| Closed | -$422K | – | 504 |
|
|
2019
Q2 | $422K | Buy |
+5,800
| New | +$422K | 0.09% | 296 |
|
|
2018
Q3 | – | Sell |
-38,500
| Closed | -$3.57M | – | 607 |
|
|
2018
Q2 | $3.57M | Buy |
38,500
+14,000
| +57% | +$1.3M | 0.8% | 12 |
|
|
2018
Q1 | $2.32M | Buy |
24,500
+10,600
| +76% | +$1M | 0.59% | 14 |
|
|
2017
Q4 | $1.34M | Sell |
13,900
-14,900
| -52% | -$1.44M | 0.27% | 112 |
|
|
2017
Q3 | $2.56M | Buy |
28,800
+24,800
| +620% | +$2.2M | 0.61% | 24 |
|
|
2017
Q2 | $290K | Buy |
+4,000
| New | +$290K | 0.11% | 297 |
|
|
2016
Q1 | – | Sell |
-3,542
| Closed | -$210K | – | 344 |
|
|
2015
Q4 | $210K | Buy |
+3,542
| New | +$210K | 0.3% | 165 |
|